12
Participants
Start Date
April 30, 2004
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Psilocybin (drug)
Capsule (.2 mg/kg).
Niacin
Active Placebo
MRI
MRI required for study inclusion for purpose of ruling out metasteses to brain
Harbor-UCLA Medical Center, Torrance
Collaborators (1)
Heffter Research Institute
OTHER
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER